Skip to content

Effectiveness of clinical pharmacist lead mobile phone education on the adherence of tuberculosis patients under NTEP Programme

Effectiveness of clinical pharmacist led mobile phone education on the adherence of tuberculosis patients under NTEP Programme- A double centre, Quasi Experimental Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024941
Enrollment
496
Registered
2020-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A157- Primary respiratory tuberculosis

Interventions

Intervention1: Intervention care Group: Patients in this group will receive mobile phone education along with standard treatment and care as per NTEP standard Control Intervention1: Standard Care Grou

Sponsors

Dr T Rajavardhana
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient with greater 18 years of age both Male and female diagnosed with tuberculosis (Pulmonary TB), Patients who are willing to participate in the study and has given written informed consent were included into the study.

Exclusion criteria

Exclusion criteria: Pregnant and lactating women Patients with other co-morbid conditions like liver & renal compromised. Patients with psychiatric disorder Patients who doesnâ??t have mobile phones. Patients who could not cooperate for study related procedure.

Design outcomes

Primary

MeasureTime frame
To determine the effectiveness of clinical pharmacist lead patient education on the adherence of tuberculosis patients.Timepoint: 0,1,2,3,4,5 and 6 months

Secondary

MeasureTime frame
To assess the reasons for non-adherence to anti tubercular treatment (ATT) using urine drug metabolite testing of ATT in both centers before the interventionTimepoint: 0,1,2,3,4,5 and 6 months

Countries

India

Contacts

Public ContactDr Meka Geethavani

Sri Ramachandra Institute of Higher Education and Research

mgrpharm@gmail.com917598464723

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 11, 2026